Market Place
Sourcing Support
Enforcement Report - Week of June 26, 2024
26 Jun 2024 //
FDA
Enforcement Report - Week of May 15, 2024
15 May 2024 //
FDA
Breckenridge Pharma`s Generic Rivaroxaban Receives Approval in the U.S.
24 Jan 2024 //
FDA
Natco Pharma and Breckenridge dismissed from antitrust lawsuit
21 Dec 2023 //
INDIAN PHARMA POST
Breckenridge Distillery Announces Beer Collaboration With Breckenridge Brewery
19 Oct 2022 //
GLOBENEWSWIRE
Breckenridge Announces Approval of its ANDA for Cabazitaxel Intravenous Solution
01 Aug 2022 //
PRNEWSWIRE
Natco Pharma`s partner Breckenridge gets FDA nod for prostate cancer drug
25 Jul 2022 //
ECONOMIC TIMES
Breckenridge`s Generic Cabazitaxel Receives Approval in US
23 Jun 2022 //
FDA
Breckenridge Distillery to Release New Collectors Art Series with Denver
25 Apr 2022 //
GLOBENEWSWIRE
Breckenridge Announces Tentative Approval of its ANDA for Dabigatran Etexilate
22 Apr 2022 //
PRNEWSWIRE
Breckenridge Signs New-Product Agreement with PTS Pharma
22 Apr 2022 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Miglustat Capsules
21 Apr 2022 //
PRNEWSWIRE
Breckenridge Announces Launch of Penicillamine Capsules, USP
20 Apr 2022 //
PRNEWSWIRE
Breckenridge Launches Lacosamide Tablets Manufactured by MSN Laboratories
19 Apr 2022 //
PRNEWSWIRE
Breckenridge Pharma launches generic Afinitor in US market
01 Oct 2021 //
PHARMABIZ
Breckenridge Announces Launch of its 10mg strength for Everolimus Tab
01 Oct 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
29 Sep 2021 //
PRNEWSWIRE
Breckenridge`s Generic Teriflunomide Receives Approval In US
24 Sep 2021 //
FDA
Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP
20 Aug 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Apixaban Tablets
05 Aug 2021 //
PRNEWSWIRE
Breckenridge Announces Launch of Zolpidem Tartrate Extended-Release Tablets
08 Jul 2021 //
PR NEWSWIRE
Breckenridge Signs Multi-Product Agreement With Aggrega Pharma LLC
22 Jun 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
PRNEWSWIRE
Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder
16 Jun 2021 //
BIOSPACE
Enforcement Report - Week of March 24, 2021
24 Mar 2021 //
FDA
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets
08 Mar 2021 //
PRNEWSWIRE
Breckenridge got Final Approval of its ANDA for Asenapine 5 mg Sublingual Tablet
08 Mar 2021 //
PRNEWSWIRE
Breckenridge Announces Final Approval of its ANDA for Asenapine Tablets
11 Dec 2020 //
PRNEWSWIRE
Natco Pharma’s partner, Breckenridge Pharma gets US FDA approval
16 Nov 2020 //
PHARMABIZ
Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules
13 Nov 2020 //
PRNEWSWIRE
Breckenridge Pharmaceutical`s Generic Acetazolamide Receives Approval In US
02 May 2020 //
FDA
Enforcement Report - Week of March 25, 2020
25 Mar 2020 //
FDA
Breckenridge Announces Final Approval of its ANDA for Rivastigmine
02 Dec 2019 //
PR NEWSWIRE
Natco, Onyx settle cancer drug patent litigation
01 Jun 2019 //
ECONOMIC TIMES
Breckenridge Pharm`s Generic Eszopiclone Receives Approval in US
15 May 2019 //
FDA
Breckenridge Pharm`s Generic Apixaban Receives Tentative Approval in US
17 Dec 2018 //
FDA
Enforcement Report - Week of November 21, 2018
21 Nov 2018 //
FDA
Breckenridge Pharm`s Generic Clobazam Receives Approval in US
24 Oct 2018 //
FDA
Breckenridge Pharm`s Generic Lansoprazole Receives Approval in US
24 Oct 2018 //
FDA
Pomalyst (Pomalidomide) : Celgene Corp. vs. Breckenridge Pharma
19 Oct 2018 //
PATENT LITIGATION
Breckenridge Pharm`s Generic RoflumilastReceives Approval in US
09 Oct 2018 //
FDA
Breckenridge Announces Final ANDA Approval of Roflumilast Tablets
06 Oct 2018 //
PR NEWSWIRE
Breckenridge Pharma`s Generic Eplerenone Receives Approval in US
20 Sep 2018 //
FDA
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Breckenridge Announces Approval for 40mg Duloxetine Delayed-release Capsules
21 May 2018 //
PR NEWSWIRE
JDRF, ADA and Helmsley Charitable Trust Issue Request for Proposals
11 Apr 2018 //
PRESS RELEASE
Breckenridge announces approval of Hep B virus tablets
02 Apr 2018 //
BIOSPECTRUM
Breckenridge`s Announces Final Approval of its ANDA Entecavir tablets Baraclude®
27 Mar 2018 //
PR NEWSWIRE
Kyprolis® (Carfilzomib):Onyx Therapeutics, Inc. v. Breckenridge Pharmaceutical
16 Feb 2018 //
PATENT LITIGATION
Breckenridge Pharm`s Generic Megestrol Acetate Receives Approval In US
06 Dec 2017 //
FDA
Breckenridge Pharmaceutical, Inc. Announces Acquisition of 5 ANDA`s
03 Oct 2017 //
PR NEWSWIRE
